Matches in Wikidata for { <http://www.wikidata.org/entity/Q64271258> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q64271258 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q64271258 description "im März 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q64271258 description "scientific article published on 23 January 2019" @default.
- Q64271258 description "wetenschappelijk artikel" @default.
- Q64271258 description "наукова стаття, опублікована в березні 2019" @default.
- Q64271258 name "Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050" @default.
- Q64271258 name "Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050" @default.
- Q64271258 type Item @default.
- Q64271258 label "Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050" @default.
- Q64271258 label "Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050" @default.
- Q64271258 prefLabel "Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050" @default.
- Q64271258 prefLabel "Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050" @default.
- Q64271258 P1433 Q64271258-D7DE5D25-DC1F-49D5-8167-E7CD8E0264C2 @default.
- Q64271258 P1476 Q64271258-5F552CF5-2BB6-42FD-9E9C-4F4F5C303FA0 @default.
- Q64271258 P2093 Q64271258-09FE1745-BEB2-461C-B0F9-579CDE83CA8E @default.
- Q64271258 P2093 Q64271258-1524C57F-0A98-4639-9C25-DE853285BA7F @default.
- Q64271258 P2093 Q64271258-26E954BD-48B7-4FE5-818D-8160D49FFA0A @default.
- Q64271258 P2093 Q64271258-38442642-CC8A-47C0-A2C5-B762B3B2D532 @default.
- Q64271258 P2093 Q64271258-57A48F84-55CA-4FA0-8E10-8B239FDD81AC @default.
- Q64271258 P2093 Q64271258-85808797-0224-4F86-AB16-12DF48C2553A @default.
- Q64271258 P2093 Q64271258-8C586A6B-32F6-4523-87A8-974DC528E6A1 @default.
- Q64271258 P2093 Q64271258-F141ECF5-DA57-48D0-ABCD-244F3355A35C @default.
- Q64271258 P304 Q64271258-AC6EC586-104E-454D-9271-8641ADEBF3EA @default.
- Q64271258 P31 Q64271258-2660A664-5CBB-4133-9815-25F1586BB6E9 @default.
- Q64271258 P31 Q64271258-BBB1668A-6A7C-4660-9AC6-81552C13846C @default.
- Q64271258 P356 Q64271258-76128966-8A01-4625-86CC-C7625F256D6D @default.
- Q64271258 P407 Q64271258-602C3A24-E25A-4C99-802E-42396BDC7D13 @default.
- Q64271258 P433 Q64271258-3E41FC2D-91CE-47B4-B5D1-65B35B3840EE @default.
- Q64271258 P478 Q64271258-226FC45F-1348-4DE5-B368-22CFFEE4FD04 @default.
- Q64271258 P50 Q64271258-84BD6BCE-6FF2-4550-9B27-949EFCEE3C81 @default.
- Q64271258 P50 Q64271258-F90934A7-0E54-42ED-A632-A6912DC4757C @default.
- Q64271258 P577 Q64271258-A692E57A-B367-4A00-BCCE-E5E8C640AFD7 @default.
- Q64271258 P698 Q64271258-8A37C85C-B4B3-4913-9D7A-6E01313D61A0 @default.
- Q64271258 P921 Q64271258-743FF332-6788-495A-8F25-6C30F18B6FB1 @default.
- Q64271258 P921 Q64271258-746D4A4E-3449-4303-99CE-B48BAFF5161F @default.
- Q64271258 P921 Q64271258-F57554C7-AEFE-49E2-9789-2C0C79049868 @default.
- Q64271258 P932 Q64271258-87DE255F-F8C5-4841-81CD-AF9C4DDDBBC4 @default.
- Q64271258 P356 DC19-ER03 @default.
- Q64271258 P698 30674545 @default.
- Q64271258 P1433 Q5270111 @default.
- Q64271258 P1476 "Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050" @default.
- Q64271258 P2093 "A H Jan Danser" @default.
- Q64271258 P2093 "Daniel H van Raalte" @default.
- Q64271258 P2093 "Jaap A Joles" @default.
- Q64271258 P2093 "Lennart Tonneijck" @default.
- Q64271258 P2093 "Marcel H A Muskiet" @default.
- Q64271258 P2093 "Mark H H Kramer" @default.
- Q64271258 P2093 "Mark M Smits" @default.
- Q64271258 P2093 "Piet M Ter Wee" @default.
- Q64271258 P304 "494" @default.
- Q64271258 P31 Q13442814 @default.
- Q64271258 P31 Q1348305 @default.
- Q64271258 P356 "10.2337/DC19-ER03" @default.
- Q64271258 P407 Q1860 @default.
- Q64271258 P433 "3" @default.
- Q64271258 P478 "42" @default.
- Q64271258 P50 Q108578052 @default.
- Q64271258 P50 Q57011856 @default.
- Q64271258 P577 "2019-01-23T00:00:00Z" @default.
- Q64271258 P698 "30674545" @default.
- Q64271258 P921 Q269829 @default.
- Q64271258 P921 Q3025883 @default.
- Q64271258 P921 Q40598164 @default.
- Q64271258 P932 "6385692" @default.